Genicular Artery Embolization (GAE) is a minimally invasive treatment for chronic knee pain caused by osteoarthritis. Learn how the procedure works and who may be a candidate.
If you have chronic knee pain from osteoarthritis and feel stuck between cortisone injections that wear off and a knee replacement you're not ready for, there's a relatively new option worth knowing about: Genicular Artery Embolization, or GAE. It's a minimally invasive, outpatient procedure that treats the underlying cause of arthritic knee pain without surgery, anesthesia, or a long recovery. In this article, we'll answer the most common questions patients ask about GAE, what it is, how it works, who it's for, and what the evidence actually shows.
Genicular Artery Embolization is a minimally invasive procedure performed by an interventional specialist to treat chronic knee pain caused by osteoarthritis. During GAE, a thin catheter is guided through a pinhole in the groin to the small arteries that supply the knee joint, called the genicular arteries. Tiny particles, smaller than a grain of sand, are then injected into the specific arteries feeding the inflamed tissue inside your knee. Those abnormal vessels are blocked; the normal blood supply to your leg and knee is preserved.
The procedure takes roughly one hour, uses only local anesthesia with light sedation, and patients walk out the same day. There are no stitches, no cast, and no extended rehabilitation.
This is the part most patients are never told, and it's important, because it explains why GAE works.
Knee osteoarthritis is usually described as wear and tear of the cartilage. That's true, but it's only part of the story. The dominant source of pain in an arthritic knee isn't actually the cartilage, it's the synovium, a thin lining inside the joint that produces lubricating fluid. In a healthy knee, the synovium is smooth and barely visible. In an arthritic knee, it becomes thickened, inflamed, and grows abnormal new blood vessels that carry pain signaling nerve fibers into the joint.
These new vessels and their companion nerve fibers amplify pain far beyond what the cartilage damage alone would cause. It's why two patients can have identical X-ray findings and completely different levels of pain, and why simply treating the inflamed synovium can produce dramatic relief even when the cartilage damage stays the same.
The key insight: GAE doesn't regrow cartilage. It shuts off the abnormal blood supply that feeds the inflammation and the pain signals. That's why it can help patients with advanced cartilage wear, it's treating the pain generator, not the structural damage.
GAE was developed specifically for patients in what doctors call the treatment gap, people whose knee pain has outgrown conservative care but who aren't ready for, or can't safely undergo, knee replacement surgery. You may be a good candidate if:
GAE is generally not recommended if you have severe peripheral artery disease, an active infection in or around the knee, advanced kidney disease that would make contrast imaging unsafe, or an uncontrollable allergy to contrast dye.
Across more than a dozen published studies including over 500 patients, roughly 78 to 92% of patients experienced clinically meaningful improvement in pain and function at 12 months after GAE. The larger series and 2-year follow-up data suggest that for patients who respond well in the first few months, the relief is often durable.
It's important to be candid: the sham-controlled randomized trials, where some patients get the real procedure and others get a placebo procedure, have shown mixed results. One such trial showed a clear benefit of GAE over placebo; two did not. However, a closer analysis of one trial revealed that patients who received complete embolization of all the inflamed branches did significantly better than placebo, while those who received incomplete treatment did not. This suggests the technique and completeness of the procedure matter a great deal, which is why choosing an experienced operator matters.
Larger trials are ongoing, including the multicenter MOTION study comparing GAE directly to cortisone injections, which will give clearer answers in the future.
The day of the procedure looks like this: You arrive in the morning, check in, and change into a gown. A small IV is placed for light sedation, which keeps you comfortable and relaxed but does not put you to sleep. The skin over your groin is numbed with local anesthesia, and a catheter about the diameter of a coffee stirrer is advanced through the artery there.
Using live X-ray imaging (angiography), the catheter is guided to each of the small arteries feeding the inflamed areas of your knee. A contrast dye is injected to see which vessels are abnormal, these show up as a bright blush corresponding to the inflammation. Once the target vessels are identified, tiny particles are slowly released to block them. After the embolization, a follow-up X-ray confirms the abnormal vessels are treated and the main blood supply is preserved.
An ice pack is placed on the knee during the procedure, a simple but important step that reduces the risk of skin-related side effects. The entire procedure typically takes about an hour. Afterward, you rest briefly in recovery and go home the same day.
Most patients walk out the same day and return to normal activity within 24 to 48 hours. Some mild soreness in the knee is common for three to seven days afterward, this is actually a sign the inflammation is being resolved and responds well to over-the-counter pain relievers. Bruising at the groin access site is minor and usually fades within a week.
Pain relief can begin within a few days for some patients, but for many it develops gradually over the first one to three months as the treated vessels scar down and synovial inflammation subsides.
GAE has a favorable safety profile when performed by experienced operators. The most common side effect is temporary skin discoloration or mottling around the knee, which looks alarming but is nearly always self-limited and fades on its own within a few weeks. The ice pack used during the procedure substantially reduces this risk. Other minor side effects include bruising at the access site and transient knee soreness. Serious complications such as skin breakdown, infection, or allergic reaction to contrast are uncommon.
GAE is not a replacement for a total knee replacement when replacement is clearly needed. What it can do is offer meaningful pain relief for patients who aren't candidates for surgery, who want to delay surgery, or who simply aren't ready to commit to a major operation. Many patients are able to defer knee replacement by years; some find the relief so durable they never need surgery at all. It's best thought of as a bridge, a way to get your life back while preserving all your future options.
The best way to find out if GAE might help your knee pain is a consultation. We'll review your knee pain history, any prior imaging and treatments, and examine your knee to look for the inflammatory features that respond best to GAE. If you're a good candidate, we'll walk you through what to expect, discuss insurance coverage, and schedule you at a time that works for you. If GAE isn't the right fit, we'll tell you honestly and help you think through other options.
If chronic knee pain is keeping you from the life you want, you don't have to choose between cortisone shots that wear off and a surgery you're not ready for. Dr. Rishi Panchal and the team at IVY Cardiovascular & Vein Center offer advanced minimally invasive treatment options like Genicular Artery Embolization to help patients regain mobility and improve quality of life. Call 561-210-9495 to schedule an appointment or conveniently schedule online today.

As an Ivy League-trained cardiologist and advanced vein specialist, Dr. Rishi Panchal is passionate about quality patient care and believes in using technological advancements to improve the patient’s quality of life, without having to undergo invasive surgical procedures without necessity.
Join our mailing list for exclusive updates and content from Dr. Panchal.